昊海生物科技(06826.HK)A股異常波動 無應披露重大信息
格隆匯8月4日丨昊海生物科技(06826.HK)發佈公告,公司A股股票交易連續三個交易日(2020年7月31日、2020年8月3日、2020年8月4日)內收盤價格漲幅偏離值累計超過30%,根據《上海證券交易所交易規則》、《上海證券交易所科創板股票交易特別規定》、《上海證券交易所科創板股票異常交易實時監控細則(試行)》的有關規定,屬於股票交易異常波動情形。
經自查,公司目前日常經營情況正常,未發生重大變化。公司於2020年3月27日披露了2019年年度報告、2019年年度利潤分配方案等,於2020年4月30日披露了未經審計的2020年第一季度季報。
公司就相關規定的重大事項進行了核查,並經向公司控股股東、實際控制人書面問詢,截至本公告披露日,公司不存在影響公司股票交易異常波動的重大事項,不存在其他應披露而未披露的重大信息,包括但不限於重大資產重組、發行股份、上市公司收購、債務重組、業務重組、資產剝離和資產注入等重大事項。
公司關注到近期有證券機構發佈的研究報告中對公司未來的盈利情況進行了單方面預測,相關數據未經公司確認,請投資者注意投資風險,具體數據以公司在中國證監會指定信披媒體披露的公開信息為準。
截止2020年8月4日,公司收盤價為189.92元/股。根據中證指數有限公司發佈的數據,公司最新市盈率為91.1倍,公司最新滾動市盈率為132.64倍。公司所處的醫藥製造業最近一個月平均滾動市盈率為57.37倍。公司特別提醒廣大投資者,注意投資風險,理性決策,審慎投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.